20 Participants Needed

Powered Prosthetics for Knee Amputations

SF
LH
Overseen ByLevi Hargrove, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Shirley Ryan AbilityLab
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores how powered prosthetics can improve walking for individuals with above-knee amputations. Researchers aim to determine if adding power to the knee, the ankle, or both can enhance walking ease and efficiency. Participants will test various prosthetic combinations, including the SRALab Hybrid Knee and SRALab Polycentric Powered Ankle, and receive training to identify the most effective option. Ideal candidates have a transfemoral amputation (above the knee), have used a prosthetic leg for at least six months, and can walk 50 meters unaided.

As an unphased trial, this study allows participants to contribute to innovative research that could enhance mobility for many.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. Please consult with the study team or your doctor for guidance.

What prior data suggests that these powered prosthetics are safe for transfemoral amputees?

Research has shown that powered prosthetic devices, such as the SRALab Hybrid Knee and SRALab Polycentric Powered Ankle, are generally easy for users to handle. In studies where participants tried these devices, researchers found no major safety issues. For instance, one study with a 70-year-old man who had a leg amputation demonstrated that he could use these devices effectively after some training. This suggests they can be safe and manageable with proper guidance.

These devices are part of research aimed at improving walking for people with above-knee amputations. They are not yet approved for widespread use, so researchers continue to closely monitor safety. While some minor discomfort or adjustment issues might occur, major problems are not commonly reported.12345

Why are researchers excited about this trial?

Researchers are excited about the SRALab Hybrid Knee and SRALab Polycentric Powered Ankle because these devices offer dynamic, powered support that closely mimics natural leg movement, unlike current prosthetic options like the Ottobock C-Leg, which primarily offer passive support. The Hybrid Knee's advanced microprocessor technology adjusts in real-time to the user's movement, providing smoother transitions and more natural walking patterns. Meanwhile, the Polycentric Powered Ankle enhances stability and adaptability across various terrains, potentially improving balance and reducing the effort required for walking. These innovations aim to empower users with greater mobility and independence, sparking hope for a significant leap in quality of life for those with knee amputations.

What evidence suggests that these prosthetic devices are effective for improving ambulation in knee amputees?

This trial will evaluate the effectiveness of powered prosthetics, such as the SRALab Hybrid Knee and SRALab Polycentric Powered Ankle, for individuals with knee amputations. Research has shown that these powered prosthetics can greatly improve walking compared to non-powered prosthetics. Participants will be assigned to different arms, receiving either the SRALab devices or other prosthetic combinations like the Ottobock Cleg4 and foot. These devices add strength to the missing joints, helping users walk more naturally and efficiently. Early results suggest that powering both the knee and ankle might further boost walking ability. With focused training on these powered devices, users may experience even greater improvements, leading to better mobility in everyday life.13567

Are You a Good Fit for This Trial?

This trial is for K2-level transfemoral amputees, meaning individuals who have had an above-knee amputation and can walk with a cane or crutches. The study aims to understand the impact of powered prosthetic knees and ankles on their walking ability.

Inclusion Criteria

It has been over 6 months since I got my final prosthesis.
I have had one leg amputated above the knee.
Medically cleared by physician to participate in study
See 2 more

Exclusion Criteria

I understand and can follow the study's requirements.
Significant new injury that would prevent use of a prosthesis
Significant other comorbidity
See 1 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Baseline Assessment

Baseline data collection with Ottobock Cleg 4/Ottobock foot or clinically prescribed microprocessor knee unit/foot

1 week
1 visit (in-person)

Condition A: CLeg + Polycentric Ankle

Participants are fit with the CLeg + Polycentric Ankle and undergo device tuning and functional outcome assessments

3 weeks
4 visits (in-person)

Condition B: SRALab Hybrid Knee + Passive Ankle

Participants switch to SRALab Hybrid Knee + Passive Ankle and repeat the protocol for device tuning and assessments

3 weeks
4 visits (in-person)

Intensive Training

Participants receive intensive clinical training with the SRALab Hybrid Knee + Polycentric Ankle

8 weeks
16 visits (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks
2 visits (in-person)

What Are the Treatments Tested in This Trial?

Interventions

  • SRALab Hybrid Knee and SRALab Polycentric Powered Ankle
Trial Overview The study compares different combinations of prosthetic limbs: a passive microprocessor knee (Ottobock CLeg4) with either an Ottobock foot or polycentric ankle, and a powered knee (SRALAB Hybrid Knee) with either a passive or polycentric powered ankle.
How Is the Trial Designed?
3Treatment groups
Experimental Treatment
Active Control
Group I: Transfemoral Amputee participants: SRALAB Hybrid knee + Polycentric Ankle, Ottobock Cleg4 + OB footExperimental Treatment2 Interventions
Group II: Transfemoral Amputee participants: Ottobock CLeg4 + Polycentric Ankle, Hybrid Knee + Passive AnkleExperimental Treatment2 Interventions
Group III: Transfemoral Amputee participants: Ottobock Cleg4 + Ottobock foot; Hybrid Knee + Polycentric AnkleActive Control2 Interventions

SRALab Hybrid Knee and SRALab Polycentric Powered Ankle is already approved in United States for the following indications:

🇺🇸
Approved in United States as SRALab Hybrid Knee and SRALab Polycentric Powered Ankle for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

Shirley Ryan AbilityLab

Lead Sponsor

Trials
212
Recruited
17,900+

Published Research Related to This Trial

In a study involving 20 male above-knee amputees fitted with a new UCBL four-bar polycentric knee prosthesis, 16 participants reported benefits from the device, with 7 considering it superior to their previous prosthetics after an average follow-up of 12.3 months.
Most subjects experienced maintained or enhanced functionality, particularly noting improved ease of walking on inclines and increased knee flexion, although some initial mechanical issues were resolved during the study.
Subjective evaluation of the UCBL polycentric knee linkage by active above knee amputees. A prospective trial.Jergesen, HE., Hoaglund, FT., Roberts, RA.[2022]
Three service members with unilateral transfemoral limb loss quickly became proficient with a powered knee-ankle (PKA) prosthesis after just three training sessions, indicating that the device can be effectively learned in a short time frame.
While the PKA prosthesis showed a 4% lower cost of transport at slower speeds, it resulted in greater compensatory movements (like trunk flexion and rotation) compared to standard prostheses, highlighting the need for tailored training to optimize functional outcomes for different populations.
Functional Performance Outcomes of a Powered Knee-Ankle Prosthesis in Service Members With Unilateral Transfemoral Limb Loss.Knight, AD., Jayaraman, C., Elrod, JM., et al.[2023]
The Power Knee (PK) prosthetic knee unit generates more power during stair descent compared to the C-Leg, potentially reducing the strain on the nondisabled limb during these activities.
While the PK helps lessen the power needed from the nondisabled knee during stair climbing, it does not outperform the C-Leg in other tasks, indicating that further improvements are needed for optimal function.
Assessment of transfemoral amputees using C-Leg and Power Knee for ascending and descending inclines and steps.Wolf, EJ., Everding, VQ., Linberg, AL., et al.[2019]

Citations

Powered Prosthetics for Knee AmputationsWhat data supports the effectiveness of the treatment SRALab Hybrid Knee and SRALab Polycentric Powered Ankle for knee amputations? Research on similar ...
Understanding How Powered Componentry Impacts K2-Level ...The goal of this study is to understand how providing power at the knee or ankle individually, or providing power at both the knee and ankle, ...
Amputation Clinical Trials - Policy LabA listing of 39 Amputation clinical trials actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
Evaluation of a Lightweight Powered LegWe have designed a lightweight powered leg with innovative knee and ankle designs that significantly reduce weight and noise while providing necessary power ...
Powered knee and ankle prosthesis use with a K2 level ...Powered prosthetic knees and ankles have the capability of restoring power to the missing joints and potential to provide increased functional mobility to ...
Powered knee and ankle prosthesis use with a K2 level ...We trained a 70 year old male participant with a unilateral transfemoral amputation to use a powered knee and powered ankle prosthesis.
Intuitive Control of a Hybrid Prosthetic Leg During AmbulationThe objective of this research is to determine the clinical benefits of an innovative and lightweight powered leg controlled using our intent recognition ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security